Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs ciprofol vs remimazolam for anesthesia safety in painless GI endoscopy in tumor patients with different BMI
ChiCTR2600125893Phase 3Not yet recruiting
- Sponsor
- Yunnan Cancer Hospital
- Start
- Jun 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Nonhematologic neoplasms and cancer comparing Propofol group, Ciprofol group and Remimazolam group (3 arms). Primary endpoints: Circulatory fluctuations and Respiratory depression. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
propofolciprofolremimazolam
03
Conditions
Nonhematologic neoplasmscancer
Beyond the preview
Go deeper on ChiCTR2600125893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125893.